These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions. Wada T; Toga A; Sakakibara Y; Toma T; Hasegawa M; Takehara K; Shigemura T; Agematsu K; Yachie A Int J Hematol; 2012 Oct; 96(4):443-9. PubMed ID: 22886572 [TBL] [Abstract][Full Text] [Related]
12. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection. Chen CC; Chang KC; Medeiros LJ; Lee JY Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336 [TBL] [Abstract][Full Text] [Related]
13. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684 [TBL] [Abstract][Full Text] [Related]
15. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease. Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500 [TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation. Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up. Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]